[State of art on the role of ischemic time in ST-segment elevation myocardial infarction treated with PTCA]

Area of Science:

• Cardiology
• Emergency Medicine
• Clinical Research

Context:

• ST-segment elevation myocardial infarction (STEMI) presents a significant clinical and epidemiological challenge due to high incidence and mortality rates.
• Effective management hinges on rapid diagnosis, prompt patient transport, and timely restoration of coronary blood flow to ischemic myocardial tissue.
• The time to reperfusion is a critical determinant in mitigating acute phase pathology and preventing long-term cardiac dysfunction.

Purpose:

• To provide a comprehensive review of the international literature concerning the critical timing of interventions in STEMI.
• To highlight the findings of recent research emphasizing the importance of reperfusion within 90 minutes of acute myocardial infarction (AMI) symptom onset.
• To advocate for a critical reassessment of current clinical guidelines based on emerging evidence for optimized STEMI therapy.

Summary:

• Early reperfusion therapy is the sole intervention capable of altering the natural progression of STEMI.
• Research indicates that reperfusion within 90 minutes of symptom onset is fundamental for improving patient outcomes.
• A critical review of existing guidelines is necessary to enhance the therapeutic strategies for acute myocardial infarction.

Impact:

• This review underscores the urgent need to align clinical practice with evidence-based reperfusion timelines.
• Optimizing treatment timing can significantly reduce mortality and long-term complications associated with STEMI.
• The findings support the revision of current guidelines to ensure more effective and timely management of STEMI patients.